Clinical Trial Update: High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II [Phase 2]

View source ↗

Summary

Phase 2 TAXIF II evaluated high-dose chemotherapy with autologous stem cell transplantation in patients with poor-prognosis germ-cell tumors. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors
• Testicular Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Testicular Neoplasms | Phase 2 | Status: COMPLETED